XML 23 R1.htm IDEA: XBRL DOCUMENT v3.25.1
Cover - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Dec. 31, 2024
Mar. 31, 2025
Jun. 28, 2024
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2024    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2024    
Current Fiscal Year End Date --12-31    
Entity File Number 001-42374    
Entity Registrant Name GLUCOTRACK, INC.    
Entity Central Index Key 0001506983    
Entity Tax Identification Number 98-0668934    
Entity Incorporation, State or Country Code DE    
Entity Address, Address Line One 301 Route 17 North    
Entity Address, Address Line Two Suite 800    
Entity Address, City or Town Rutherford    
Entity Address, State or Province NJ    
Entity Address, Postal Zip Code 07070    
City Area Code (201)    
Local Phone Number 842-7715    
Title of 12(b) Security Common Stock, par value $0.001 per share    
Trading Symbol GCTK    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 8.6
Entity Common Stock, Shares Outstanding   25,585,853  
Documents Incorporated by Reference [Text Block] None    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Entity Listing, Par Value Per Share $ 0.001    
Auditor Firm ID 1375    
Auditor Opinion [Text Block] We have audited the accompanying consolidated balance sheets of Glucotrack Inc. a Delaware corporation (the “Company”) as of December 31, 2024, and 2023, the related consolidated statements of operations and comprehensive loss, changes in stockholders’ equity and cash flows for each of the two years in the period ended December 31, 2024, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024, and 2023, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America    
Auditor Name FAHN KANNE & CO. GRANT THORNTON ISRAEL    
Auditor Location Tel-Aviv, Israel